Advances in BABE

 In pharmacology, bioavailability (BA) is a subcategory of ingestion and is the part of a managed measurement of unaltered medication that achieves the systemic flow, one of the important pharmacokinetic properties of medications. Bioavailability is one of the crucial apparatuses in pharmacokinetics, as bioavailability must be considered when computing doses for non-intravenous courses of organization.

 

  • Application of Nano technology to improve bioavailabilty
  • Innovative strategies
  • Isotope drug studies in man
  • Bioequivalence Criteria
  • Risks in bioequivalence assessment
  • Requirement to determine the active principle
  • Relevance of bioequivalence in approving generic copies of drug products
  • Electronic regulatory submission and review
  • Electronic regulatory submission and review
  • Drug application regulatory compliance
  • New drug quality assessment
  • Highly variable and low permeable drugs
  • Complex generics

Related Conference of Advances in BABE

July 14-15, 2025

15th World Glycobiology Congress

Berlin, Germany
July 17-18, 2025

16th International Conference on Biofuels and Bioenergy

Amsterdam, Netherlands
September 08-09, 2025

23rd International Conference on Structural Biology

Frankfurt, Germany

Advances in BABE Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in